Sign up Australia
Proactive Investors - Run By Investors For Investors

BetterCells to show off testing capacity at wellness hub IPO information session

The investor event starts at 3pm on the main drag of the trendy Perth suburb of Mt Lawley.
BetterCells to show off testing capacity at wellness hub IPO information session
Investors will take a hands-on approach to evaluating the company

BetterCells Ltd will conduct spot tests of prospective investors’ levels of heavy metals such as mercury and aluminium at an initial public offering information session this Wednesday in Perth.

The private company will conduct the two-minute hand-scans for prospective investors who registered for the session online and signed up for the $99 test that also looks at key mineral levels such as iodine and selenium.

Results from the tests can be fed into a health-conscious individual’s private profile at the BetterCells wellness hub.

The BetterCells hub helps people determine what to do if they have high heavy metals readings or low vital minerals.

READ: BetterCells drives personal health care solution with ‘better mind, better body’ focus

 

Perth-based BetterCells is commercialising the hub in partnership with test providers and consultants and will take investors through its prospectus at the event to be held in the suburb of Mt Lawley.

Investors will converge at restaurant Peaky Bodega, at 677 Beaufort Street in the trendy inner-city suburb, at 3pm this Wednesday for the two-hour session.

To register, email to [email protected].

View full . profile View Profile

BetterCells Ltd Timeline

Related Articles

Once the phase III trial is completed, Futura plans to either sell off the asset or find a partner
September 26 2018
The pharma group expects to dose the first patient in the Phase III trial of its MED2002 erectile dysfunction treatment within the next month
1538160791_petri-dishes.jpg
September 29 2018
The biotech group revealed it had brought in $9.1mln via an oversubscribed placing
surgeons working
September 03 2018
Chief executive Steve Couldwell also told investors the regenerative medicines specialist had identified a number of potential new commercial opportunities it was “actively pursuing”

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use